3rd Circ. To Hear Appeal Of Cert. In Provigil Antitrust Row
The Third Circuit has agreed to hear Mylan Pharmaceuticals Inc. and Ranbaxy Pharmaceuticals Inc.'s appeal of a lower court's grant of class certification to direct buyers of narcolepsy drug Provigil who...To view the full article, register now.
Already a subscriber? Click here to view full article